在使用芬太尼尔的患者中,布普伦诺芬启动的障碍
Sarah S Kawasaki1, Jane M Liebschutz2,3, Cristina Murray-Krezan2,4
1Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
JAMA network open
|January 6, 2026
概括
临床医生经常在使用芬太尼的患者中遇到难以启动布普伦诺芬 (BUP) 治疗的困难,这往往导致急于戒断. 许多从业者修改标准的BUP诱导协议来应对这些挑战,特别是在非住院环境中.
科学领域:
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 事证据表明,在使用非法制造的芬太尼的人群中,开始治疗布普伦诺芬 (BUP) 的挑战越来越大.
- 关于这些困难的患病率和性质的经验数据有限.
研究的目的:
- 确定在使用芬太尼的患者中启动BUP治疗时临床医生报告的问题的频率.
- 描述用于克服BUP治疗启动和患者参与方面的挑战的临床策略.
主要方法:
- 对医生和高级实践临床医生进行了在线调查.
- 该调查收集了有关患者使用芬太尼的数据,BUP诱导问题 (急性/长期戒断) 和临床医生报告的策略.
- 后勤回归确定了与BUP启动问题相关的因素.
主要成果:
- 超过72%的临床医生报告了在使用芬太尼的患者中启动BUP的问题.
- 超过61%的患者报告说他们经历了急性戒断.
- 患者数量较多的临床医生,使用芬太尼的患者比例较高的临床医生,以及在非住院环境中执业的临床医生更有可能报告启动问题.
结论:
- 在使用芬太尼尔的患者中,启动布普伦诺芬治疗具有重大挑战,包括迅速停药.
- 许多临床医生根据这些困难而调整他们的诱导程序和咨询.
- 需要进一步的研究来开发和验证适合特定临床环境的替代性BUP诱导策略.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
906
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
906
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Opioid Receptors: Overview
4.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K
Opioid Analgesics: Morphine and Other Natural Cogeners
841
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
841
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K


